 In the Phase II study, 40 patients will be enrolled in a prospective observational open label, dose escalation study of safety and efficacy of local anesthetic infusion into the sternal wound. Outcome measures for efficacy will be visual analog pain VAP scores and opioid consumption. Outcome measures for safety will be plasma ropivacaine concentrations and adverse events. 